Cancer patients who took immune therapies such as Merck & Co.’s Keytruda or Bristol-Myers Squibb Co.’s Opdivo showed a greater risk of developing heart problems in a study.
Among women with breast cancer, colorectal cancer, or melanoma, those who were taking cholesterol-lowering medications, were less likely to die from cancer. The analysis was published in the
Small, close-knit communities are at high risk for rapid, intense COVID outbreaks especially if they haven’t yet experienced outbreaks of COVID-19, shows a new study by the University
FRIDAY, Oct. 2, 2020 (American Heart Association News) — Belinda Zuniga was searching the classified ads for job notices 14 years ago when a single word caught her
In general, surgeons who perform numerous cataract operations every year encounter relatively few severe cases, and this probably contributes to their lower complication rate, as shown by a
An international, multi-billion-dollar race is underway to develop a COVID-19 vaccine, and progress is moving at record speed, but with nationalistic, competitive undertones. If and when an effective
New research on Alzheimer’s disease led by the University at Buffalo reveals strong evidence that clinical trials on drugs that appeared not to benefit patients with the disease
While about a quarter of physicians and researchers working in advanced heart failure (HF) and transplant cardiology are women, representation of women leading HF research remains limited, according
Hockey goaltenders could have a new competitive advantage in stopping the puck thanks to researchers at Brock University. Professor of Kinesiology Kelly Lockwood and graduate student Colin Dunne
Researchers at McMaster University who study how the brain processes sound have discovered the common practice of using artificial tones in perception experiments could mean scientists are overlooking
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok
